Guanhao Biotech Co.,Ltd.

Equities

300238

CNE100001575

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-28 pm EDT 5-day change 1st Jan Change
9.91 CNY +4.10% Intraday chart for Guanhao Biotech Co.,Ltd. +10.97% -26.92%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Guanhao Biotech Co.,Ltd. Announces Management Appointments CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Chinese Shares Finish Higher; Guanhao Biotech Rallies 20% on 500 Million Yuan Deal With Largest Shareholders MT
Guanhao Biotech’s Actual Controllers to Boost Stake to 39% in 500 Million Yuan Deal; Shares Rally 20% MT
Guanhao Biotech Co.,Ltd. announced that it expects to receive CNY 500 million in funding from Beijing Century Tianfu Venture Capital Center (Limited Partnership), Beijing Tianyou Investment Co., Ltd., Jiangsu Tianyou Jingan Investment Co., Ltd. CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020 CI
Wuhan Constant Science & Technology Co., Ltd. cancelled the acquisition of 26.5% stake in Guangzhou Junsun Medical Technology Co Ltd from Guanhao Biotech Co.,Ltd.. CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020 CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019 CI
Guanhao Biotech Co.,Ltd. Announces Board Changes CI
Tibet Xinyi Investment Co., Ltd. cancelled the acquisition of 20% stake in Guangzhou Youvision Biotech Co., Ltd. from Guanhao Biotech Co.,Ltd.. CI
Wuhan Constant Science & Technology Co., Ltd. entered into an agreement to acquire 26.5% stake in Guangzhou Junsun Medical Technology Co Ltd from Guanhao Biotech Co.,Ltd. for CNY 1. CI
Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2019 CI
Chart Guanhao Biotech Co.,Ltd.
More charts
Guanhao Biotech Co., Ltd. is a China-based company principally engaged in the research, development, production and distribution of regeneration medical materials and medical implanted devices. The Company primarily provides biological dura mater patches, chest general surgery department patching membranes (type P) and (type B), asepsis biological wound-surface protection membranes, type B dura matrix, intraocular lens as well as agent products. The Company is also engaged in provision of related technological services.
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300238 Stock
  4. News Guanhao Biotech Co.,Ltd.
  5. Guanhao Biotech’s Actual Controllers to Boost Stake to 39% in 500 Million Yuan Deal; Shares Rally 20%